{"disease":{"id":"beta-thalassemia","name":"beta Thalassemia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"luspatercept","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reblozyl","generic_name":"LUSPATERCEPT","company_name":"Celgene Corp","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11","drug_class":"Erythroid Maturation Agent [EPC]","quality_score":60,"revenue":"2327","mechanism":"Reblozyl works by binding to growth/differentiation factor 11, promoting the maturation of red blood cells."},{"drug_id":"reblozyl","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Reblozyl","company_name":"EuroBloodNet Association","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11, Growth/differentiation factor 8","drug_class":"","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"exjade","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Exjade","company_name":"DisperSol Technologies, LLC","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH), Lysine-specific demethylase 5A","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"luspatercept-aamt","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"REBLOZYL","generic_name":"LUSPATERCEPT-AAMT","company_name":"CELGENE CORP","drug_phase":"marketed","molecular_target":"Growth/differentiation factor 11, Growth/differentiation factor 8","drug_class":"Erythroid Maturation Agent [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"deferasirox","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exjade","generic_name":"DEFERASIROX","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Flavin reductase (NADPH)","drug_class":"Iron Chelator [EPC]","quality_score":10,"revenue":null,"mechanism":"Exjade works by binding to iron in the body and removing it through the urine."},{"drug_id":"deferiprone","indication_name":"beta Thalassemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ferriprox","generic_name":"DEFERIPRONE","company_name":"Chiesi","drug_phase":"marketed","molecular_target":"Deoxyhypusine hydroxylase","drug_class":"Iron Chelator [EPC]","quality_score":75,"revenue":null,"mechanism":"Ferriprox works by binding to iron in the body and removing it, thereby reducing iron overload."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT04918056","title":"Genetic Variants Affecting the Clinical Severity of Beta Thalassemia","phase":"","overall_status":"UNKNOWN","enrollment_count":1300,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04929574","title":"Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04917978","title":"Association of Hb F Level With Clinical Severity of Beta Thalassemia","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06539169","title":"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT04064060","title":"A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":665,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT03947632","title":"Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT02604433","title":"An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT03937817","title":"Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03462784","title":"Complications in Children With B- Thalassemia Major","phase":"","overall_status":"UNKNOWN","enrollment_count":201,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06568926","title":"Adherence of Beta Thalssemia Patients to Oral Chelation Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06146478","title":"Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Blood Care Clinic","has_results":false},{"nct_id":"NCT04973280","title":"Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06509581","title":"Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05469230","title":"Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT04208529","title":"A Long-term Follow-up Study in Participants Who Received CTX001","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07292259","title":"Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Pakistan Blood and Marrow Transplant (PBMT) Group","has_results":false},{"nct_id":"NCT05506358","title":"Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada","phase":"NA","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"University of British Columbia","has_results":true},{"nct_id":"NCT03894605","title":"Dermatological Abnormalities in Beta-thalassemia Major","phase":"","overall_status":"UNKNOWN","enrollment_count":125,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06512298","title":"Plasticizer Exposure and Its Consequences on Health","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT00000588","title":"Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT07099196","title":"Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.","phase":"NA","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Mohammed Bin Rashid University of Medicine and Health Sciences","has_results":false},{"nct_id":"NCT06073860","title":"A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia","phase":"","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03376893","title":"Epidemiology of Silent and Overt Strokes in Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT07153926","title":"Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Thalassemia","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT04219449","title":"Thrombophilia In Beta Thalassemia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06664541","title":"Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT02626689","title":"To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT07480980","title":"Evaluation of Micro RNA-155 Expression in Relation to Alloantibody Formation in Transfusion-Dependent Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07486531","title":"Iron Accumulation in Erythrocytes in Patients","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT05991336","title":"Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04143724","title":"Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":99,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06606886","title":"Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Bahria University","has_results":false},{"nct_id":"NCT06421636","title":"A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":95,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05567458","title":"A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":94,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07509996","title":"Risk Factors Affecting Growth in Thalassemic Children at AUCH","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03381833","title":"A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":84,"lead_sponsor_name":"La Jolla Pharmaceutical Company","has_results":false},{"nct_id":"NCT03851055","title":"Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT07288762","title":"Gonadal Function in Thalassemic Patient","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT07370922","title":"Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04691323","title":"The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT07157722","title":"Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT02998450","title":"A Study of IMR-687 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Cardurion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03591575","title":"Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Chiesi Canada Corp","has_results":true},{"nct_id":"NCT03728543","title":"the Efficacy and Safety of Sugammadex in Children 0-2 Years Old","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","has_results":false},{"nct_id":"NCT04067258","title":"Choroidal Thickness in Beta-thalassemia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University Hospital of Patras","has_results":false},{"nct_id":"NCT06980662","title":"The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ataturk University","has_results":false},{"nct_id":"NCT03655678","title":"A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}